Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the woocommerce domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/m2farma/wp-includes/functions.php on line 6114

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordfence domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/m2farma/wp-includes/functions.php on line 6114

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the rocket domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/m2farma/wp-includes/functions.php on line 6114

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/m2farma/wp-includes/functions.php on line 6114
Anvisa aprova novo medicamento a base de Cannabis - M2farma

Anvisa aprova novo medicamento a base de Cannabis

A Agência Nacional de Vigilância Sanitária (Anvisa) aprovou, nesta segunda-feira (28/11), por meio da Resolução RE n° 3.893, de 24 de novembro de 2022, a autorização sanitária de mais um produto medicinal à base de Cannabis a ser fabricado no Brasil.

O produto aprovado é o CANABIDIOL EASE LABS 100 MG/ML, a ser fabricado pela EASE LABS LABORATÓRIO FARMACÊUTICO LTDA. em território nacional, sob a forma de solução de uso oral, contendo 100 mg/mL de canabidiol (CBD) e não mais que 0,2% de tetrahidrocanabinol (THC).

A comercialização do produto será feita em farmácias e drogarias a partir da prescrição médica por meio de receita especial do tipo B (de cor azul).

A Anvisa já aprovou 23 produtos de Cannabis com base na RDC n° 327/2019, sendo 9 à base de extratos de Cannabis sativa e 14 de canabidiol.

Os produtos de Cannabis aprovados pela Anvisa até o momento são:

  • Canabidiol Ease Labs 100 mg/mL;
  • Canabidiol Prati-Donaduzzi (20 mg/mL; 50 mg/mL e 200 mg/mL);
  • Canabidiol NuNature (17,18 mg/mL);
  • Canabidiol NuNature (34,36 mg/mL);
  • Canabidiol Farmanguinhos (200 mg/mL);
  • Canabidiol Verdemed (50 mg/mL);
  • Extrato de Cannabis sativa Promediol (200 mg/mL);
  • Extrato de Cannabis sativa Zion Medpharma (200 mg/mL);
  • Canabidiol Verdemed (23,75 mg/mL);
  • Extrato de Cannabis sativa Cann10 Pharma (200 mg/mL);
  • Extrato de Cannabis sativa Greencare (79,14 mg/mL);
  • Extrato de Cannabis sativa Ease Labs (79,14 mg/mL);
  • Canabidiol Belcher150 mg/mL;
  • Canabidiol Aura Pharma 50 mg/mL;
  • Canabidiol Greencare23,75 mg/mL;
  • Canabidiol Active Pharmaceutica (20 mg/mL);
  • Extrato de Cannabis sativa Greencare (160,32 mg/mL);
  • Extrato de Cannabis sativa Mantecorp Farmasa (160,32 mg/mL);
  • Extrato de Cannabis sativa Mantecorp Farmasa (79,14 mg/mL);
  • Canabidiol Promediol (200 mg/mL);
  • Canabidiol Collect (20 mg/mL);
  • Canabidiol Mantecorp Farmasa (23,75 mg/mL); e
  • Extrato de Cannabis sativa Cannabr 10 mg/mL.

A consulta aos produtos de Cannabis aprovados pela Anvisa pode ser feita por meio do seguinte link do portal da Agência: https://consultas.anvisa.gov.br/#/cannabis/

Fonte: Anvisa